T0	Participants 108 133	irritable bowel syndrome.
T1	Participants 297 341	patients with irritable bowel syndrome (IBS)
T2	Participants 642 655	IBS patients.
T3	Participants 664 715	Patients with IBS according to the Rome II criteria